Back to Search
MARK FRAMPTON, MD
MD
Pulmonary Disease Physician
NPI: 1710917877IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
120325(NY)
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1973
Research & Publications (20)
Does inhalation of ultrafine particles cause pulmonary vascular effects in humans?
PMID 17886054·Inhal Toxicol·2007
6-review
Inhalation of ultrafine particles alters blood leukocyte expression of adhesion molecules in humans.
PMID 16393658·Environ Health Perspect·2006
8-other
Effects of exposure to ultrafine carbon particles in healthy subjects and subjects with asthma.
PMID 15768531·Res Rep Health Eff Inst·2004
4-observational
Nitrogen dioxide exposure: effects on airway and blood cells.
PMID 11741827·Am J Physiol Lung Cell Mol Physiol·2002
3-trial
Systemic and cardiovascular effects of airway injury and inflammation: ultrafine particle exposure in humans.
PMID 11544158·Environ Health Perspect·2001
6-review
ECG parameters and exposure to carbon ultrafine particles in young healthy subjects.
PMID 18991063·Inhal Toxicol·2009
2-rct
Particulate matter (PM) research centers (1999-2005) and the role of interdisciplinary center-based research.
PMID 19270783·Environ Health Perspect·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE, BOX MED
ROCHESTER, NY 14642 - Phone
- (585) 275-4861
Quick Facts
- NPI
- 1710917877
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 53
- Publications
- 20
Are you this provider?
Claim Your Profile